Search

everythinglearnresearchcommunity

for

Search:↓

Certain Dibenzo derivatives may help treat prostate cancer.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Hand preference and sexual orientation may predict finasteride side effects in male hair loss.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Tamoxifen effectively treats gynecomastia without causing impotence.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Low-dose oral minoxidil effectively treats female hair loss with good safety.

The safety and tolerability of low-dose oral minoxidil for treating hair loss in adolescents is not clearly determined.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Finasteride effectively and safely treats recurrent priapism in children and adolescents with sickle cell disease.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Future alopecia treatments will improve with targeted therapies and personalized approaches.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Low-dose oral minoxidil improved hair growth in most pediatric patients with mild side effects.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.